diálogos ELE

CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Moramar Tygokus
Country: Netherlands
Language: English (Spanish)
Genre: Politics
Published (Last): 3 October 2017
Pages: 439
PDF File Size: 12.16 Mb
ePub File Size: 20.30 Mb
ISBN: 892-5-61823-648-6
Downloads: 31955
Price: Free* [*Free Regsitration Required]
Uploader: Voodoozil

Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome RADIANT New treatment options with cytotoxic agents in neuroendocrine tumours.

New treatment strategies in advanced neuroendocrine tumours. J Clin Oncol ;33 suppl: Entre 1 et 2 cm: Br J Cancer ; Updating the management of patients with rectal neuroendocrine tumors.

Treatment of metastatic carcinoids and devannt neuroendocrine tumors with recombinant interferon-alpha-2a. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: WHO classification of tumours of endocrine organs. Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: Comment citer ce chapitre? Comparison of efficacy and search for predictive factors guiding treatment choice.

  GREGORI WARCHAVCHIK PDF

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. TNM staging of foregut neuro endocrine tumors: Chimioembolisation [Zappa ] Contre-indications: TNE de primitif inconnu.

CAT devant ictère néonatal by Farah Marraha on Prezi

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: Fazio N, Milione M. Detection of liver metastases from endocrine tumors: World J Surg ;37 7: Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.

Review and Position Statement. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. Diagnosis and Prognostic Stratification. J Clin Endocrinol Metab.

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors–the International Lanreotide and Interferon Alfa Study Group.

WHO classification of tumours of the digestive system. Dig Liver Dis ; TNM staging of midgut and hindgut neuro endocrine tumors: Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Everolimus for advanced pancreatic neuroendocrine tumors. La classification OMS des TNE digestives ne prenait in en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1.

J 15 et J 30 puis tous les mois Clinique: Cancer Jan 15; 2: Prognostic factors influencing survival from metastatic stage IV gastroenteropancreatic well-differentiated endocrine carcinoma. Eur J Surg Oncol. O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in icterd with neuroendocrine tumors.

  ELBERT BENJAMINE PDF

Il faut y associer la classification pTNM.

11. Tumeurs neuroendocrines digestives (Dernière mise à jour le 12/10/2017)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas. TNM Classification of malignant tumours. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.

Indications du traitement antitumoral non chirurgical: Eur J Gastroenterol Hepatol. DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors.

Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

N Engl J Med.

Copy of CAT devant une péritonite by Ismail Chafik on Prezi

Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Expert Rev Anticancer Ther. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine devan. Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?